Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/224-multicenter-open-label-early-access-program-of-telaprevir-in-combination-with-peginterferon-alfa-and-ribavirin-in-genotype-1-chronic-hepatitis-c-subjects-with-severe-fibrosis-and-compensated-cirrhosis